A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer

NCT03895788 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: niraparib
DRUG: Brivanib

Sponsor

Hunan Cancer Hospital